Delivery Order SPE2DB20D7059-SPE2DB25FQAH7

Award Date 2/21/25
Potential Completion Date 2/24/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,532.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of May 23, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply CEFAZOLIN 1 G/50 ML-DEXTROSES. The $2,904.77 firm fixed-price delivery order has a completion date of July 23, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.60, is a Firm Fixed Price Delivery Order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSE medical products. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,768.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The contract provides for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, to support military treatment facilities, veterans'...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,167.92, is for the delivery of 4564171961 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 5, 2024. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,212.28 Firm Fixed Price Delivery Order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $7,639.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSE medical supplies, which are critical pharmaceutical products used in military and government healthcare settings. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 Firm Fixed Price delivery order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a delivery order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSE medical products. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQAH7
    Delivery Order

This federal contract award, valued at $2,047.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 24, 2025. The award is not associated with a set-aside program.

The contract provides for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal agencies. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/23/25, 10:05 AM